MAP2K7 and melanoma: Specifically, in NRASmut and NF1mut melanoma cell lines, the combination of entinostat with MEK inhibitors has shown to enhance tumor regression via triggering the cooperatively suppression of nonhomologous end‐joining genes, leading to a chemical synthesis lethality caused by excessive DNA damage [301].